The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study
- 13 October 2017
- journal article
- clinical trial
- Published by Springer Nature in Annals of Hematology
- Vol. 96 (12) , 2015-2024
Abstract
There is no information about XCL1 in patients with acute lymphoblastic leukemia (ALL). The objective of this study was to correlate the serum levels of XCL1 and survival in ALL patients. Only ALL patients older than 12 months were considered to participate. Serum XCL1 was measured at diagnosis, end of remission induction, and end of consolidation. Thirty-three ALL patients with median age of 21 years (1-78) were included. Higher XCL1 level (above 50 pg/mL) at ALL diagnosis correlated with higher survival (p = 0.038), whereas XCL1 level at end of induction and consolidation had no significant correlation. Concerning the behavior of serum XCL1 during treatment, higher survival at 5 years was observed in the group with progressively decreased levels of XCL1 (70%) than those with progressively increasing (29%) or no detectable XCL1 (14%). In conclusion, higher serum XCL1 levels at diagnosis and their progressive decline throughout chemotherapy could be correlated with higher survival.Keywords
This publication has 29 references indexed in Scilit:
- The Possible Diagnostic and Prognostic Use of Systemic Chemokine Profiles in Clinical Medicine—The Experience in Acute Myeloid Leukemia from Disease Development and Diagnosis via Conventional Chemotherapy to Allogeneic Stem Cell TransplantationToxins, 2013
- Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantationBlood, 2012
- Intrapulmonary Delivery of XCL1-Targeting Small Interfering RNA in Mice Chronically Infected with Mycobacterium tuberculosisAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Chapter 3 Lymphotactin Structural Dynamics2009
- XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection withMycobacterium tuberculosisnegatively affects production of IFN-γ by CD4 T cells and participates in granuloma stabilityJournal of Leukocyte Biology, 2007
- A lymphotactin-producing monoclonal T-cell lymphoproliferative disorder with extreme lymphocytopenia and progressive leukoencephalopathyLeukemia & Lymphoma, 2006
- Concentration of IL‐2, IL‐6, IL‐8, IL‐10 and TNF‐alpha in children with acute lymphoblastic leukemia after cessation of chemotherapyHematological Oncology, 2004
- Neutrophils and B Cells Express XCR1 Receptor and Chemotactically Respond to LymphotactinBiochemical and Biophysical Research Communications, 2001
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- Adenoviral Vectors Expressing Lymphotactin and Interleukin 2 or Lymphotactin and Interleukin 12 Synergize to Facilitate Tumor Regression in Murine Breast Cancer ModelsHuman Gene Therapy, 1999